top of page

CO₂ reactivity as a biomarker of non-response to exposure-based therapy

Cognitive behavior therapy (CBT) is an effective treatment for anxiety and fear-related disorders. However, some patients fail to achieve complete remission or show a return of anxiety symptoms following treatment. The purpose of the study is to determine the extent to which one’s emotional reaction to a CO₂ inhalation task can help predict who might or might not respond to therapy. If CO₂ reactivity proves to be successful in predicting who will benefit from CBT versus who will not, clinicians can make better decisions about which patients should be treated with CBT.

Power in Numbers

Power in Numbers

National Institute of Mental Health

Sponsor

2

Locations

Currently recruiting participants

Status

Clinical Trials Registry

2016-09-0150

IRB Protocol

Study Related Content

Training

File Folders

Files

N/A

File Folders

Publications

Forum

N/A

bottom of page